152 related articles for article (PubMed ID: 36384721)
21. Growing Trend of China's Contribution to Global Diabetes Research: A Systematic Literature Review.
Zhao X; Guo L; Yuan M; He X; Lin Y; Gu C; Li Q; Zhao L; Tong X
Medicine (Baltimore); 2016 May; 95(18):e3517. PubMed ID: 27149452
[TBL] [Abstract][Full Text] [Related]
22. Iodine-131 Tositumomab: (131)I-anti-B1 antibody, (131)I-tositumomab, anti-CD20 murine monoclonal antibody-I-131, B1, Bexxar, (131)I-anti-B1 antibody, iodine-131 tositumomab, iodine-131 anti-B1 antibody, tositumomab.
BioDrugs; 2003; 17(4):290-5. PubMed ID: 12899647
[TBL] [Abstract][Full Text] [Related]
23. [Early achievements of the Danish pharmaceutical industry-7].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2014; (42):31-62. PubMed ID: 25816561
[TBL] [Abstract][Full Text] [Related]
24. Methylglyoxal, A Metabolite Increased in Diabetes is Associated with Insulin Resistance, Vascular Dysfunction and Neuropathies.
Shamsaldeen YA; Mackenzie LS; Lione LA; Benham CD
Curr Drug Metab; 2016; 17(4):359-67. PubMed ID: 26965039
[TBL] [Abstract][Full Text] [Related]
25. Independent research and development, technology accumulation and innovation performance: Evidence from China's pharmaceutical manufacturing industry.
Wang S; Liu Q; Chen Y
PLoS One; 2022; 17(4):e0266768. PubMed ID: 35390101
[TBL] [Abstract][Full Text] [Related]
26. [Analysis on the trend of innovation and development in the field of ophthalmology].
Shan LH; An XY; Xu MM; Fan SP; Zhong H; Ni P; Chi H
Zhonghua Yan Ke Za Zhi; 2018 Jun; 54(6):452-463. PubMed ID: 29895120
[No Abstract] [Full Text] [Related]
27. Obstacles and opportunities in Chinese pharmaceutical innovation.
Ni J; Zhao J; Ung CO; Hu Y; Hu H; Wang Y
Global Health; 2017 Mar; 13(1):21. PubMed ID: 28340579
[TBL] [Abstract][Full Text] [Related]
28. Diet, nutrition and diabetes mellitus.
Vessby B; Karlström B; Ohrvall M; Järvi A; Andersson A; Basu S
Ups J Med Sci; 2000; 105(2):151-60. PubMed ID: 11095111
[TBL] [Abstract][Full Text] [Related]
29. [Considerations on Clinical Development and Regulatory of the Oversea License-in
Anti-tumor Drugs].
Zhao X; Hao R; Tong X; Zou L; Tang L; Zhang H; Xia L; Yang Z
Zhongguo Fei Ai Za Zhi; 2022 Jul; 25(7):448-451. PubMed ID: 35899440
[TBL] [Abstract][Full Text] [Related]
30. Zinc and type 2 diabetes mellitus with periodontitis – a systematic review.
Pushparani DS
Curr Diabetes Rev; 2014; 10(6):397-401. PubMed ID: 25413995
[TBL] [Abstract][Full Text] [Related]
31. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2016; (43):9-61. PubMed ID: 27491172
[TBL] [Abstract][Full Text] [Related]
32. Progress on familial hypercholesterolemia.
Jiang WZ; Zhang LW; He CH; Ruan MH; Ji Y; Yu JR; Zhou HW
Yi Chuan; 2021 Nov; 43(11):1011-1022. PubMed ID: 34815205
[TBL] [Abstract][Full Text] [Related]
33. Exploring the Development of Chinese Digital Resources under Lightweight Deep Learning.
Song B
Comput Intell Neurosci; 2022; 2022():3759129. PubMed ID: 35814587
[TBL] [Abstract][Full Text] [Related]
34. Drug policy in China. Transformations, current status and future prospects.
Liu X; Li S
Pharmacoeconomics; 1997 Jul; 12(1):1-9. PubMed ID: 10169383
[TBL] [Abstract][Full Text] [Related]
35. Diabetic dyslipidemia.
Kreisberg RA
Am J Cardiol; 1998 Dec; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
[TBL] [Abstract][Full Text] [Related]
36. Novel Bluetooth-Enabled Tubeless Insulin Pump: A User Experience Design Approach for a Connected Digital Diabetes Management Platform.
Pillalamarri SS; Huyett LM; Abdel-Malek A
J Diabetes Sci Technol; 2018 Nov; 12(6):1132-1142. PubMed ID: 30304951
[TBL] [Abstract][Full Text] [Related]
37. Different associations of diabetes with β-cell dysfunction and insulin resistance among obese and nonobese Chinese women with prior gestational diabetes mellitus.
Li W; Zhang S; Liu H; Wang L; Zhang C; Leng J; Yu Z; Yang X; Tian H; Hu G
Diabetes Care; 2014 Sep; 37(9):2533-9. PubMed ID: 24914241
[TBL] [Abstract][Full Text] [Related]
38. Recent Advances in the Treatment of Insulin Resistance Targeting Molecular and Metabolic Pathways: Fighting a Losing Battle?
Wolosowicz M; Prokopiuk S; Kaminski TW
Medicina (Kaunas); 2022 Mar; 58(4):. PubMed ID: 35454311
[TBL] [Abstract][Full Text] [Related]
39. Plasma cell membrane glycoprotein 1 (PC-1): a marker of insulin resistance in obesity, uremia and diabetes mellitus.
Stefanović V; Antić S
Clin Lab; 2004; 50(5-6):271-8. PubMed ID: 15209435
[TBL] [Abstract][Full Text] [Related]
40. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
Morrison EY; Ragoobirsingh D; Peter SA
Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
